Results 101 to 110 of about 2,887 (179)
Olmesartan medoxomil for the treatment of hypertension in children and adolescents
Vascular Health and Risk Management, 2011 Giuliano Tocci1, Massimo Volpe1,21Chair and Division of Cardiology, Department of Clinical and Molecular Medicine, Faculty of Medicine, University of Rome “Sapienza”, Sant’Andrea Hospital, Rome; 2IRCCS Neuromed, Pozzilli, ItalyAbstract:
Volpe M, Tocci G
doaj
Design of Olmesartan Medoxomil-Loaded Nanosponges for Hypertension and Lung Cancer Treatments. [PDF]
Polymers (Basel), 2021 Almutairy BK +5 more
europepmc +1 more source
, 2003 To compare the antihypertensive efficacy of olmesartan medoxomil with that of candesartan cilexetil after 1, 2 and 8 weeks of treatment. Randomised, double-blind, parallel-group study conducted at 44 centres in Germany, Poland and the Czech Republic. 643
Stumpe, K.O. +2 more
core +1 more source
Кардиоваскулярная терапия и профилактика, 1970 Aim. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study was a double-blind trial in patients with hypertension at increased cardiovascular risk with carotid wall thickening and a defined atherosclerotic plaque that used non ...
Kl. O. Stumpe +7 more
doaj
Vascular Health and Risk Management, 2008 Luis M RuilopeUnidad de Hipertensión, Hospital 12 de Octubre, Madrid, SpainAbstract: Hypertension is a major risk factor for cardiovascular disease that contributes to the premature death of millions of people each year, and identification and ...
Luis M Ruilope
doaj
The Clinical Efficacy of Clopidogrel Bisulfate Tablets Combined with Olmesartan Medoxomil for Ischemic Stroke with Hypertension and the Effect of Angiotensin II Type 1 Receptor Level on Prognosis. [PDF]
Comput Math Methods Med, 2021 Yu J +6 more
europepmc +1 more source
, 2017 Çalışmada, ciddi bir halk sağlığı sorunu olan hipertansiyon tedavisinde oral yoldan kullanılan, RAS blokeri seçici bir Anjiyotensin II reseptör tip I (AT1) antagonisti olan olmesartan medoksomilin biyoyararlanımını geliştirdiğimiz mikro/nanoemülsiyonla ...
Komesli, Yelda
core
Rapid and selective UV Spectrophotometric method for the analysis of Olmesartan medoxomil in bulk and dosage form. [PDF]
, 2012 A new UV spectrophotometric method was developed for quantitative evalution of Olmesartan medoxomil preparations. The UV detector was set at 256nm. Beers law is obeyed in the concentration range of 2.0 -14.0 øg/ml.
D. Gowrishankar +2 more
core
Background: Olmesartan medoxomil is a selective angiotensin II receptor blocker extensively prescribed for the management of hypertension. Despite its therapeutic efficacy, the drug exhibits poor aqueous solubility, resulting in slow dissolution and ...
E. Manasa +2 more
core +1 more source
Российский кардиологический журнал, 2010 The VIOS (Vascular Improvement with Olmesartan medoxomil Study) study is a randomized, parallel study to determine the relative effects of suppressing the renin-angiotensin system (RAS) with the angiotensin receptor antagonist olmesartan medoxomil versus
Ronald D. Smith +6 more
doaj